What Sonic Genetics does

Sonic Genetics is a genetic testing division and brand of Sonic Healthcare Limited (ASX:SHL), one of Australia's largest medical diagnostic companies, headquartered in Sydney, New South Wales. The company delivers a broad clinical genetic testing portfolio processed through Sonic Laboratories, spanning reproductive health (Non-Invasive Prenatal Testing, Reproductive Carrier Screening, Fetal Rhesus Screening), pharmacogenomics (Sonic Pgx), cancer genetics (Find It hotspot panel, Prosigna breast cancer assay), and testing for familial disorders, immunology, paediatric disorders, haematological and solid malignancies, lactose intolerance, familial hypercholesterolaemia, and DNA relationship verification. Genetic counselling is offered as an adjunct service across categories.

The business operates a hybrid go-to-market model. The primary channel is clinician-directed ordering through the Sonic Healthcare network, where doctors, pathologists, and genetic counsellors request tests via clinician portals, request forms, and specimen collection at Sonic's national collection centre footprint. A direct-to-consumer layer supports self-service ordering and online payment for selected tests, most prominently NIPT, through the company's website. Marketing is split between clinician-facing medical education (Sonic Education platform, electronic newsletters, clinical resources) and patient-facing website content.

Revenue is generated on a fee-for-service basis: per-test billing to patients and healthcare providers, with Medicare rebates supplementing eligible tests including reproductive carrier screening and familial hypercholesterolaemia from November 2023. The company serves two primary customer segments — healthcare professionals (enterprise-style ordering) and individual patients (consumer self-service for selected tests) — across a domestic-only Australian geographic footprint.

Name

Sonic Genetics

Legal name

Sonic Genetics

Website

https://sonicgenetics.com.au

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Sonic Genetics is a Sydney-based genetic testing division of Sonic Healthcare (ASX:SHL), providing NIPT, reproductive carrier screening, pharmacogenomics, and cancer genetics through Sonic Laboratories. It serves Australian clinicians and patients via clinician-led ordering, DTC NIPT, and Medicare-rebated testing.

Ownership category

akta.pro rank

Product category

Genetic Testing Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

akta.pro secondary industries

Genetic & Prenatal Testing Laboratories (HLAFAMAH), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Genetic testing services
• Prenatal screening tests
• Reproductive carrier screening
• Pharmacogenomic testing
• Cancer genetics diagnostics

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Genetic Testing Services: Fee-for-service genetic testing delivered through Sonic Laboratories. Revenue generated from test processing fees billed to patients, healthcare providers, and funded through Medicare rebates where eligible.
2. Medicare Rebates: Medicare rebates available for specific tests including reproductive carrier screening (cystic fibrosis, spinal muscular atrophy, fragile X syndrome) and familial hypercholesterolaemia testing from November 2023.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Sonic Genetics delivers clinical genetic testing services through Sonic Laboratories in Australia, spanning reproductive health (NIPT, reproductive carrier screening, fetal Rhesus screening), pharmacogenomics (Sonic Pgx panel), cancer genetics (hotspot panels and Prosigna), familial hypercholesterolaemia, immunology, paediatric, and haematological/solid malignancy testing. Tests are ordered by healthcare professionals or, in the case of NIPT, directly by patients, with Medicare rebates available for eligible indications and genetic counselling offered as a supporting service.

Product overview

Sonic Genetics provides a comprehensive genetic testing service operating through Sonic Laboratories in Australia. The company offers a portfolio of genetic tests organized into major categories: reproductive health services including Non-invasive Prenatal Testing (NIPT) and Reproductive Carrier Screening (RCS) with Medicare rebates; pharmacogenomics testing (Sonic Pgx panel) for personalized medication; cancer genetics including hotspot panels and Prosigna; and general genetic testing for familial disorders, immunology conditions, paediatric disorders, haematological and solid malignancies. Additional services include DNA relationship testing, lactose intolerance testing, familial hypercholesterolaemia testing, and fetal Rhesus screening. Genetic counselling is available as a supporting service across all test categories.

Differentiator

Problem solved

Functional benefit

Brands

• Sonic Pgx: Pharmacogenomic testing panel that helps doctors personalize medication according to patient's genetic variation.

Products and services

• Non-invasive Prenatal Testing (NIPT) Blood test performed on expectant mothers that screens for common genetic conditions such as Down syndrome. Also referred to as NIPS or non-invasive prenatal screening. Available to patients via clinician order or self-referral through the Sonic Genetics website payment portal.
• Reproductive Carrier Screening (RCS) Blood test for parents that identifies if they carry genetic changes (mutations) that could cause certain genetic conditions in their child. Includes three-gene panel (cystic fibrosis, spinal muscular atrophy, fragile X syndrome) eligible for Medicare rebate.
• Pharmacogenomics (Sonic Pgx) Genetic test (Sonic Pgx panel) that analyzes genes involved in drug metabolism and hypersensitivity, helping clinicians prescribe medications optimally based on patient genetic variation.
• Lactose Intolerance Testing Genetic test to confirm if a person can digest lactose (the sugar in milk and dairy products). Used for diagnosis in both children and adults.
• Cancer Genetics Genetic testing services for cancer risk assessment and characterisation, including the Find It cancer hotspot panel and the Prosigna assay for breast cancer prognosis.
• Familial Hypercholesterolaemia (FH) Testing Genetic testing for familial hypercholesterolaemia with Medicare rebate available, supporting diagnosis and management of inherited high cholesterol.
• DNA Relationship Testing DNA testing to accurately determine biological relationships for families and individuals, including paternity and other relationship testing.
• Familial Disorders Testing Genetic testing to identify inherited conditions, supporting early diagnosis and informed patient care for familial disorders.
• Immunology Testing Analysis of genes modifying the risk of disease or responsible for familial disorders of the immune system.
• Oncology - Haematological Malignancies Testing Genetic tests to help clinicians characterise attributes of blood cancers and guide therapy and patient management.
• Oncology - Solid Malignancies Testing Assays providing information beyond histological examination to help guide diagnosis, therapy, and monitoring of solid tumour cancers.
• Paediatric Disorders Testing Genetic testing for paediatric disorders to identify conditions early and support diagnosis, treatment, and care for children.
• Genetic Counselling Professional genetic counselling services to help patients understand test results, make informed decisions, and cope with genetic conditions.
• Fetal Rhesus Screening Screening for fetal Rhesus status in Rh-D negative pregnant patients, with Medicare rebate available for non-alloimmunised patients from 11-weeks gestation.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Invitae: Invitae (now part of Labcorp) offers comprehensive germline genetic testing across reproductive, cancer, and paediatric indications. Highly comparable to Sonic Genetics' broad test menu and clinician-ordering business model.
• Myriad Genetics: Myriad is a US genetic testing company focused on hereditary cancer (BRACAnalysis, myRisk), pharmacogenomics, and prenatal screening. Closely comparable to Sonic Genetics' cancer genetics and PGx portfolio, addressing similar clinician-driven demand for personalised medicine.
• Natera: Natera is a US-based genetic testing company specialising in reproductive health (NIPT via Panorama), oncology, and organ transplant monitoring. Directly comparable to Sonic Genetics on NIPT and reproductive carrier screening offerings and competes for the same clinician ordering channel globally.
• Exact Sciences (Genomic Health): Exact Sciences (which acquired Genomic Health, the maker of Oncotype DX) operates in oncology molecular diagnostics, comparable to Sonic Genetics' Prosigna breast cancer prognosis offering and broader cancer-genetics franchise.

Broad incumbents

• Labcorp (Laboratory Corporation of America): Labcorp is a large US clinical laboratory network offering a broad menu including reproductive, oncology, and pharmacogenomic genetic tests. Comparable as a broad incumbent with overlapping capabilities and similar B2B clinician ordering motion.
• Quest Diagnostics: Quest Diagnostics is a major US clinical laboratory providing routine and specialty genetic testing (including NIPT and hereditary cancer panels). Comparable as a broad-incumbent lab services peer with similar payer relationships and clinician channel.
• Eurofins Genoma / Eurofins Genomics: Eurofins operates a global network of clinical diagnostics and genetics laboratories, including reproductive and hereditary testing. Comparable as a broad incumbent genetic testing services provider with much greater geographic scale.

Regional players

• Australian Clinical Labs: Australian Clinical Labs is a major Australian pathology provider offering genetic and specialty diagnostics. Comparable as a domestic competitor for clinician-ordered genetic testing within the same Australian geography.
• Healius (formerly Primary Health Care): Healius operates one of Australia's largest pathology networks (Laverty, QML, Dorevitch) and competes directly with Sonic Healthcare for clinician-ordered diagnostics. A regional peer because it serves the same Australian market with overlapping reproductive and general pathology services.

Emerging players

• GeneDx: GeneDx (acquired by Sema4, now publicly traded) focuses on rare-disease, paediatric, and hereditary genetic testing. Comparable to Sonic Genetics' paediatric and familial-disorder test menu, though with a US-centric operating base.

Market position

Competitive moat3 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sonic-genetic

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sonic Genetics